Crinetics Pharmaceuticals CRNX
NASDAQ CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Receivables - Net (2025 - 2026)

Crinetics Pharmaceuticals (CRNX) posted quarterly Receivables - Net of $5.7 million for Q1 2026, up 859.97% quarter-over-quarter from $592000.0 in Q4 2025.

Analysis

Crinetics Pharmaceuticals (CRNX) Receivables - Net (2025 - 2026) Analysis & Trends

Crinetics Pharmaceuticals' Receivables - Net history runs 5 years deep, the most recent figure standing at $5.7 million for Q1 2026.

  • In Q1 2026, Receivables - Net changed N/A year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.7 million (changed N/A YoY), while the FY2025 annual figure was $592000.0, changed N/A from the prior year.
  • Receivables - Net for Q1 2026 stood at $5.7 million, up from $592000.0 in the prior quarter.
  • The five-year high for Receivables - Net was $5.7 million in Q1 2026, with the low at $592000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.96 Mn
Mar 31, 2026 5.68 Mn
Dec 31, 2025 592,000.00